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Sumrlrlary 
A number of distinct functional abnormalities have been observed in B ceils derived from pS0/ 
NF-KB or c-rel knockout mice. RelB, another member of the NF-KB/Rel family of transcrip- 
tion factors, is expressed during the latter stages of B cell maturation and can bind to regulatory 
sites  within  the  Ig heavy chain  locus.  Therefore,  we  tested  the  ability  of B  ceils  from relB 
knockout mice (relB -/-) to proliferate, undergo maturation to IgM secretion, and switch to the 
expression  of downstream  Ig isotypes in  response to  distinct  activators including  LPS,  anti- 
CD40 mAb or CD40 ligand, and/or dextran anti-IgD antibodies in combination with various 
cytokines, including IL-4, IL-5, IFN-3', and TGF-13. B cells lacking RelB showed up to 4-fold 
reductions in DNA synthesis in response to LPS, CD40, and membrane Ig-dependent activa- 
tion relative to controls. However, relB -/-  B cells were comparable to control B  cells in their 
ability to undergo  maturation to IgM secretion and switch to the expression of IgG3, IgG1, 
IgG2b, IgG2a, IgE, and/or IgA under all activation conditions tested. Thus, RelB, like c-Rel 
and p50/NF-KB, plays a role in B  cell proliferation. However, in contrast to c-Rel and p50/ 
NF-KB, it is not critically involved in maturation to Ig secretion or expression oflg isotypes. 
T 
he NF-KB/Rel family of transcription  factors, which 
includes p50 (and its precursor p105), p52 (and its pre- 
cursor pl00), RelA, RelB, and c-Rel, has been implicated 
in the rapid regulation of a wide array of genes involved in 
inflammation and immunity (1-3). These transcription fac- 
tors are expressed in most cell types in an inactive cytoplas- 
mic form and  can be induced  by a wide  range of stimuli 
leading to degradation of the inhibitors, collectively termed 
IKB  (4,  5).  The  NF-KB/Rel  members  form  either  ho- 
modimers  or various  combinations  of heterodimers,  pos- 
sessing  distinct  binding  affinities  for  particular  promoters 
and enhancers.  After cellular activation,  IKB is rapidly de- 
graded  allowing NF-KB/Rel  dimers  to  enter  the  nucleus 
and bind to KB consensus sequences, which are located in 
the  promoters  and  enhancers  of multiple  genes.  In  this 
manner NF-KB/Rel family members can participate in the 
transcriptional  regulation  of that gene.  Activation  of nor- 
mal murine B  ceils  through membrane (m)Ig crosslinking, 
CD40  activation,  or with LPS leads to rapid induction  of 
NF-KB  (6-8).  Further,  normal B  cells  and B  cell  tumors 
demonstrate  a patterned  expression  of NF-KB/Rel family 
members during ontogeny and upon activation (9).  Thus, 
pre-B cells express mainly p50 and p65, mature B cells pS0 
and c-Rel, and plasmacytoma lines or LPS-activated B cells 
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express p52  and RelB  along with  the  others.  Indeed,  the 
late expression of RelB has led to the suggestion that it may 
play a role in B cell maturation to Ig secretion. 
Although  the  precise  role  of the  NF-KB/ILel  family 
members  in  normal  B  cell  function  is  largely  unknown, 
multiple NF-KB/Rel binding sites  have been identified in 
the Ig heavy chain locus. Thus, p50 binding sites have been 
identified  in  the  germline promoters  ('T' regions)  of the 
constant  heavy (CH)  genes  encoding  -/3  (10),  ￿9  (11),  yl, 
and  o~  (Lin,  S.C.,  and J.  Stavnezer,  manuscript submitted 
for  publication).  In  addition,  multiple  p50  binding  sites 
have been identified in the switch regions for 3'3,  3'1,  and 
3'2b, particularly at sites  of switch recombination (12-14). 
A  recent study has also  identified functionally relevant KB 
binding sites  in a pair of Ig heavy chain enhancers located 
3' to the constant heavy gene for o~ (i.e., 3'o~E  [hsl,2]  and 
3'ci-hs4).  Specifically,  3'0~E  (hsl,2)  was  found  to  bind 
RelB,  c-Rel, and p50, whereas 3'ci-hs4 contained specific 
binding sites for RelB, p50, and p52 (15). 
Several recent  studies  have demonstrated striking func- 
tional  deficits  in B  cells  from knockout  mice deficient in 
either  c-R.el  or  p50.  Thus,  B  cells  from  c-Rel-deficient 
mice were defective in DNA synthesis in response to LPS, 
CD40  ligand,  or  mlg cross-linking,  relative  to  control  B 
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for B  cells derived from p50  knockout mice.  In this case, 
p50 -/-  B  cells were markedly defective in their prolifera- 
tive response to LPS, but showed comparable responses to 
mlg crosslinking or CD40  activation, compared to control 
B  cells (17,  18). p50 -/-  B  cells also demonstrated selective 
defects in B  cell maturation to IgM secretion, germline C. 
transcription, and Ig class switching (18). 
RelB-deficient mice  exhibit a  number  of abnormalities 
in their hematopoietic system including a reduction in the 
number  of thymic  epithelial and  dendritic cells and  mye- 
loid hyperplasia (19, 20). These abnormalities are associated 
with a mixed inflammatory cell infiltration of several organs 
and  splenomegaly  due  to  extramedullary  hematopoiesis. 
However,  although  T  and B  cell development in  relB -/ 
mice  appears grossly normal,  the  functional capacity of B 
cells derived from relB knockout mice have not been stud- 
ied.  In light of tLelB binding to  regulatory sites in  the  Ig 
hea  W  chain  locus  and  the  induction  of P,  elB  expression 
during late phases of B  cell maturation we tested the capac- 
ity of highly purified relB -/-  B  cells to proliferate, undergo 
maturation to Ig secretion, and switch to the expression of 
downstream  Ig  isotypes  in  response  to  multiple  distinct 
stimuli. 
Materials and Methods 
Mice.  Mice with a targeted disruption of the relB gene were 
originally established from relB -7+ mice of (I29/Sv X C57BL6/J) 
background and were subsequently maintained by heterozygote 
intercrosses (19). Nur77/N10-transgenic  mice lack mature T cells 
due to the expression of a Nur77/NlO  cDNA under the control 
of the T  cell-specific mouse proximal lck promoter and the hu- 
man  CD2  gene locus control region (21).  RelB-deficient mice 
that  also  express  the  Nur77/N10  transgene  are  described else- 
where (Weih, F., S.K. Durham, D.S. Barton, W.C. Sha, D. Bal- 
timore,  and  R.  Bravo,  manuscript  submitted  for  publication). 
The  first  set of experiments were performed using relB -/-  and 
relB +/+  mice. The second and third set of experiments were per- 
formed with  relB  /  Nur77/NlO  and  relB-/+Nur77/NlO  mice. 
The latter mice were used in addition to the former since they 
demonstrated  markedly reduced  pathology due  to  the  relB -/- 
phenotype in the absence of mature T  cells.  Results from both 
sets of experiments were found to be essentially equivalent. To 
minimize potential contributions from non-B cells due to differ- 
ences  in  background genes  between  the  different strains,  small 
resting relB -/-  and relB +/+ B cells were purified by electronic cell 
sorting from splenocytes pooled from multiple littermates. All an- 
imals were housed and bred within the same room in the Veteri- 
nary Sciences Department of the Bristol-Myers Squibb Pharma- 
ceutical Research Institute.  The absence  of pathogens was assessed 
by extensive periodic, comprehensive serology and histopathol- 
ogy of sentinel animals housed within the same room. 
Reagents.  HS~/1  (monoctonal mouse IgG2b [lo allotype] anti- 
mouse IgD [a allotype]) and AF3 (monoclonal mouse IgG2a [a al- 
lotype]  anti-mouse  IgD  [b  allotypel) antibodies were  purified 
from ascites. Dextran-conjugated HS"V1 and AF3 antibodies (oe8- 
dex)  were  prepared by conjugation of the respective mAbs,  to 
high molecular weight dextran (2 X  106 M.W.) as previously de- 
scribed (22). The concentration ofdextran-conjugated antibodies 
that is noted in the text reflects only the anti-Ig antibody concen- 
trations and not that of the entire dextran conjugate. Membrane- 
bound  (m)  CD40L  was  prepared from Sf9  insect cells infected 
with a CD40L-containing recombinant baculovirus vector (23). 
Anti-CD40 mAb (3/23, rat IgG2a anti-mouse CD40 mAb) (24) 
was a kind gift from G.G.B. Klaus (National Institute for Medical 
Research,  London,  England)  and was purified from  ascites.  Es- 
cherichia  coil  LPS  serotype 0111:B4,  phenol-extracted was  pur- 
chased from Sigma (St. Louis, MO). Recombinant nmrine IL-4, 
IL-5, IFN-y, and human TGF-[32 were kind gifts from Alan Le- 
vine  (Case  Western  Reserve  University  School  of Medicine, 
Cleveland, OH),  Richard Hodes (National Institutes of Health, 
Bethesda, MD), Genentech, Inc. (South San Francisco, CA), and 
Wendy Waegell (Celtrix Pharmaceuticals, Santa Clara, CA), re- 
spectively. 
Preparation  and Culture orb Cells.  Single cell suspensions  were 
made from spleen and RBCs were lysed with ACK lysing buffer. 
Cells  were  stained  with  polyclonal  goat  anti-mouse  IgM-PE 
(Southern Biotechnology Associates, Birmingham, AL) and mono- 
clonal  FITC-rat  anti-mouse  CD3e  (PharMingen,  San  Diego, 
CA).  Small, resting B  cells  (IgM+CD3 -, low forward and side 
scatter profile) were  obtained by  electronic cell sorting on  an 
EPICS  Elite cytometer (Coulter Corp, Hialeah, FL).  Reanalysis 
of sorted cells immediately after isolation showed B cell purities 
of 97-99%.  Sorted  cells  were  cultured  immediately after  their 
isolation. 
Measurement of DNA  Synthesis by [-3H/TdR Incorporation.  B  cells 
were cultured for 72 h  in a final volume of 0.2  ml in complete 
RPMI  in  flat bottom 96-well trays  (Costar,  Cambridge,  MA). 
[3H]TdR (1 #.Ci)  (Amersham Corp., Arlington Heights, IL) with 
a specific activity of 20 Ci/mmol was added to the cultures for an 
additional 18 h. Cultured cells were then harvested onto glass fi- 
ber filter paper with an LKB Wallac (Turku,  Finland) 1295-00l 
cell harvester. Specific incorporation of [3H]TdR was analyzed by 
scintillation spectroscopy and  results  are  expressed as the  arith- 
metic mean •  SEM of triplicate cultures. 
Quantitation  of Secreted  Ig  Isotype  Concentrations  iu  Cuhure  SN. 
Ig isotype concentrations were measured by an ELISA assay. For 
determination of concentrations of secreted IgM,  lgG3,  (IgG1, 
IgG2b, IgG2a), and IgA in culture SN, Immulon 2, 96-well flat- 
bottomed ELISA plates (Dynatech Laboratories, Inc., Alexandria, 
VA) were coated with unlabeled affinity-purified polyclonal goat 
anti-mouse  IgM,  lgG3,  IgG,  and  IgA  antibodies  (10  I~g/ml) 
(Southern Biotechnology Associates, Birmingham, AL), respec- 
tively. Plates were  then  washed,  blocked with  FBS-containing 
buffer,  and incubated with various dilutions of culture  SN  and 
standards.  After  washing,  plates  were  incubated  with  alkaline 
phosphatase-conjugated  affinity-purified,  polyclonal  goat  anti- 
mouse IgM, IgG3, IgG1, IgG2b, IgG2a, and IgA antibodies (100 
ng/ml) (Southern Biotechnology Associates) as indicated, washed 
again, and a fluorescent product was generated by cleavage of ex- 
ogenous 4-methyl umbilliferyl phosphate (MUP)  (Sigm~a) by the 
plate-bound alkaline phosphatase-conjugated antibodies. For de- 
termination of lgE concentrations, a similar procedure was fol- 
lowed except that plates were coated with monoclonal rat IgG2a 
anti-mouse IgE (clone EM95)  (10  b~g/ml) (purified from ascites, 
and a kind gift of Dr. Fred Finkelman, University of Cincinnati, 
Cincinnati, OH), followed by samples and standards, then mono- 
clonal biotin-rat IgG1 anti-mouse IgE (clone R35-92) (250 ng/ml) 
(PharMingen), then streptavidin-alkaline phosphatase (PharMin- 
gen) (100 ng/ml), then MUP. Fluorescence was quantitated on a 
3 M  FluoroFAST 96 fluorometer (Mountain View, CA) and fluo- 
rescence units were converted to Ig concentrations by interpola- 
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Figure 1.  B cells lacking 1kelB show modest defects in DNA synthesis relative to controls. Sort-purified resting B cells from relB  -/- and control mice 
were cultured for 72 h at 1 ￿  105 cells/ml in the presence of LPS (0.2-20 leg/ml), cx~-dex (0.03-3 ng/ml), or anti-CD40 mAb (1.25-20 leg/nil) +  IL-4 
(3,000 U/ml)  +  IL-5 (150 U/nil).  [3H]TdtL was added overnight and cells were then harvested for determination of [3H]TdR incorporation. Values 
shown represent the means of triplicate cultures -+ SEM. Similar results were obtained in two additional sets of experiments. 
tion  from  standard  curves  that  were  determined  with  known 
concentrations of purified myeloma Ig. Each assay system showed 
no significant  cross-reactivity  or interference from other Ig iso- 
types (IgM, IgD, IgG3, IgG1, IgG2b, IgG2a, IgE, and lgA) found 
in the culture supernatants. 
Results  and Discussion 
B  Cells Lacking RelB Exhibit Defects in DNA  Synthesis in Re- 
sponse to LPS, mlg or CD40 Signaling.  Activation  of normal 
murine B  cells with LPS or through engagement of CD40 
or membrane (m)Ig all induce B  cell mitogenesis, with fur- 
ther  augmentation  in  response  to  IL-4  +  IL-5,  although 
the  signal  transduction  pathways  mediating  this  event  are 
distinct.  Further,  B  cells  activated through these modalities 
show  distinctive  patterns  of Ig  secretion  and  Ig  isotype 
switching in response to specific patterns of stimuli (25).  In 
this  context,  and  in  light  of distinctive  roles  for p50  and 
c-Rel in murine B cell proliferation, we determined whether 
any of these mitogenic pathways were dependent upon the 
expression  of RelB.  Highly purified  resting  B cells  from 
relB -/-  and control mice, were obtained by electronic cell 
sorting and stimulated for 72 h with various concentrations 
of LPS,  0~8-dex  or  anti-CD40  mAb  plus  IL-4  +  IL-5. 
Comparable  results  were  obtained  in  three  independent 
experiments  which  demonstrated  up  to  4-fold  reductions 
in  DNA  synthesis  in  B  cells  lacking  RelB  compared  to 
controls  in  response  to  any of the  3  activation  modalities 
(Fig.  1). These results differ in several ways from those ob- 
tained using B cells from c-rel -/-  or p50 -/-  mice. c-rel -/-  B 
cells  show  a  more  profound  defect in  proliferation  in  re- 
sponse to mlg- or CD40-mediated signaling, although, like 
relB -/  B  cells,  exhibited  only  a  partial  proliferative  re- 
sponse to LPS, relative to control B  cells  (16). By contrast, 
p50 -/-  B cells showed a more profound proliferative defect 
in response to LPS, a partial  reduction upon CD40 activa- 
tion, and normal DNA synthesis after mlg crosslinking rel- 
ative  to  control B  cells  (17,  18).  Thus,  although  relB -/-, 
c-rel  /  , and p50 -/-  B cells all demonstrate defects in DNA 
synthesis they appear to differ (0  in the severity of the de- 
fect and  (i  0  in their capacity to respond to different mito- 
genic signals. 
B  Cells Lacking  RelB  Show Normal  Maturation  of Ig Secre- 
tion and Switching to Downstream Ig Isotypes.  A previous study 
indicated that RelB is expressed late during B  cell matura- 
tion  (9).  This  suggested  that  tkelB  could  regulate  B  cell 
maturation  to  Ig  secretion.  Further,  RelB  binding  sites 
have been identified in both 3'ciE (hsl,2) and 3'cx-hs4 (15). 
B  cells  from  mice  made  genetically  deficient  in  3'c~E 
(hsl,2)  showed selective  defects in germline  CH transcrip- 
tion and consequent Ig isotype switching (26),  implicating 
3'c~E  (hsl,2)  in  transcriptional  regulation  of CH  genes  in 
germline.  Indeed, the 3'oLE (hsl,2)  also contains p50 bind- 
ing sites  (15),  and B  cells  from p50 -/-  mice demonstrate a 
pattern  of germline  CH  expression  similar  to B  cells  from 
mice lacking 3'lxE (hsl,2)  (15, 21). The ability of LPS and 
anti-Ig to regulate  3'tie  (hsl,2)  activity in normal B  cells 
(27)  further  indicates  that  this  enhancer  is  active  during 
B cell  activation.  Thus,  we  tested  the  relative  ability  of B 
cells lacking RelB to undergo B cell maturation to IgM se- 
cretion and switch to the expression of downstream Ig iso- 
types in response to various combinations of B  cell activa- 
tors and cytokines. 
IL-4, IFN-% and TGF-[3 each induce class switching in 
appropriately  activated  mouse  B  cells;  IL-4 to  IgG1  and 
IgE; IFN-~/to IgG3 and IgG2a; and TGF-[3 to IgG2b and 
IgA (for review see reference 28).  This is accomplished, at 
least  in  large  part,  by  their  apparent  ability  to  selectively 
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B cells lacking P,.elB show normal levels of maturation to 
lgM secretion and expression of downstream lg isotypes relative to con- 
trols. Sort-purified resting B cells from relB /  and control mice were 
cultured for 6 d at 1 X 105 cells/ml in the presence of (A) LPS (20 ~g/ 
ml), (B) LPS +  IL-4 (3,000 U/ml), mCD40L (1/2,000 vol/vol)  +  IL-4 
+  IL-5 (150 U/ml),  (C) LPS +  IL-4 +  IL-5 +  ag-dex (3 ng/ml)  + 
TGF-[3 (3 ng/ml) or mCD40L +  IL-4 +  IL-5 +  clS-dex ((I.3 ng/nfl) + 
TGF-[3 (29), (D) LPS + IFN-y (10 U/ml), (E) oeS-dex  + IL-5 + IFN-y. 
After 6 d of culture, SN were harvested for determination of Ig isotype 
concentrations by ELISA. The means of duplicate cultures -+ SEM are in- 
dicated. Similar results were obtained in a second set of experiments. 
stimulate  transcriptional activation  of gem-dine  C H genes, 
thus  targeting them  for  switch  recombination.  Combina- 
tions of stimuli optimal for induction of class switching to 
different sets ofisotypes were used to assess switch recom- 
bination in  RelB -/-  B  cells. Maturation  to  IgM secretion 
was  essentially comparable between  B  cells lacking RelB 
and similarly-activated control B  cells, in response to a vari- 
ety of distinct stimuli (Fig. 2, A-E). This finding contrasted 
sharply  with  observations  made  using p50 -/-  B  cells  in 
which IgM secretion was markedly defective in response to 
LPS,  or in the presence  of cytokines to  either o~8-dex or 
CD40  activation (18).  Restoration of cytokine-dependent 
IgM  secretion  in p50 -/-  B  cells  was  accomplished  only 
with  the  combined actions of CD40L  and  o~8-dex.  Thus, 
despite its appearance late during B  cell maturation,  1LelB 
does not appear to be critical for maturation of B  cells into 
IgM-secretors. 
Likewise, induction of all 6 non-IgM, non-lgD isotypes in 
B cells lacking RelB was comparable to that observed for con- 
trol B  cells. The essentially normal levels of lgG1 and IgG3 
secretion by B  cells lacking RelB correlated with compara- 
ble percentages of membrane  (m)IgG1 + and mlgG3 + cells 
by flow cytometry, relative to similarly activated control B 
cells (data not shown). This contrasted sharply with p50 -/ 
B  cells in which class switching to IgG3, IgE, and IgA, was 
markedly  reduced  compared  to  control B  cells,  although 
induction of IgG1 was significant (18).  This was associated 
with normal steady-state levels of germline Cu~/1  and CHCi 
RNA, but markedly reduced germline CHy3 and CHe RNA 
in p50 -/- B  cells relative to controls. Studies on IgM secre- 
tion  and  class  switching  by  B  cells  from  c-tel  knockout 
mice  have  not  been  reported  (16).  However,  preliminary 
data from our laboratories indicates selective defects in germ- 
line C H RNA  expression and Ig class switching in c-tel -/- 
B  cells, disinct from that  observed in B  cells from p50 -l- 
mice (P.  Zelazowski et al., in preparation). Thus,  although 
P,.elB binding to the 3'lxE (hs  1,2),  as well as 3'lx-hs4 was 
shown  to  be  functionally relevant in  a  B  cell tumor  line 
(15),  and  3'0rE  (hsl,2)  has  been  implicated in  regulating 
germline CH transcription (26), R.elB by itself does not ap- 
pear to play a critical role in expression of any of the Ig iso- 
types. 
A  more comprehensive understanding of the role of the 
NF-KB/1Lel  family  members  in  normal  B  cell  function, 
will  require  additional  analyses  of B  cells  from  p52  and 
1<elA knockout mice plus further analyses of B  cells from 
double, and perhaps triple knockout mice. Through nmlti- 
parameter  functional  analyses  of these  model  systems,  a 
clear view of the  role of the NF-KB/R.el family in the  B 
cell functional program should emerge. 
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